Onesource Specialty Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 4.15 Cr
as on 02-07-2024
- Company Age 17 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 306.02 Cr
as on 02-07-2024
- Satisfied Charges ₹ 1,050.24 Cr
as on 02-07-2024
- Revenue 516.17%
(FY 2022)
- Profit -89.49%
(FY 2022)
- Ebitda -34.98%
(FY 2022)
- Net Worth 30.32%
(FY 2022)
- Total Assets 93.64%
(FY 2022)
About Onesource Specialty Pharma
The Corporate was formerly known as Inbiopro Solutions Private Limited. The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.15 Cr.
The company currently has active open charges totaling ₹306.02 Cr. The company has closed loans amounting to ₹1,050.24 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Onesource Specialty Pharma Limited India are Kannan Radhakrishnan as CFO and Allada Trisha as Company Secretary. Arun Pillai, Gopakumar Nair, Pudhucode Kannan, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74140KA2007PLC043095
- Company No.
043095
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Jun 2007
- Date of AGM
25 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Onesource Specialty Pharma?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neeraj Sharma  | Managing Director | 29-Mar-2024 | Current |
| Kannan Radhakrishnan | CFO | 09-Jul-2021 | Current |
| Allada Trisha | Company Secretary | 14-Mar-2023 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mahadevan Narayanamoni | Director | 26-Mar-2021 | Current |
| Arun Pillai | Director | 22-Feb-2016 | Current |
| Gopakumar Nair | Director | 04-May-2023 | Current |
| Pudhucode Kannan | Whole-Time Director and Cfo | 25-Mar-2017 | Current |
| Rajashri Ojha | Director | 04-May-2023 | Current |
| Bhushan Bopardikar | Director | 02-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Onesource Specialty Pharma.
Onesource Specialty Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 516.17% increase. The company also saw a substantial fall in profitability, with a 89.49% decrease in profit. The company's net worth Soared by an impressive increase of 30.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Onesource Specialty Pharma?
In 2022, Onesource Specialty Pharma had a promoter holding of 29.06% and a public holding of 70.94%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
United Ciigma Institute Of Medical Sciences Private LimitedActive 13 years 10 monthsMahadevan Narayanamoni is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jan 2024 | ₹0.20 M | Open |
Others Creation Date: 21 Mar 2022 | ₹20.00 Cr | Open |
Idbi Trusteeship Services Limited Creation Date: 13 May 2021 | ₹200.00 Cr | Open |
How Many Employees Work at Onesource Specialty Pharma?
Onesource Specialty Pharma has a workforce of 513 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Onesource Specialty Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onesource Specialty Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
